Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Dec 28.
Published in final edited form as: Obes Res Clin Pract. 2015 Sep 11;9(6):618–621. doi: 10.1016/j.orcp.2015.08.015

Effects of CPAP on energy expenditure in obese obstructive sleep apnoea patients: A pilot study

Ari Shechter a,*, Tiffany Pham b, Russell Rising c, Marie-Pierre St-Onge a,b
PMCID: PMC5193470  NIHMSID: NIHMS836686  PMID: 26371702

Summary

We conducted a placebo-controlled crossover pilot study investigating the effects of 2 mo of active and sham continuous positive airway pressure (CPAP) on energy expenditure (EE) via whole-room indirect calorimetry in three obese obstructive sleep apnoea (OSA) patients. Total 24-h (active: 2970 ± 254 kcal/d, sham: 2705 ± 217 kcal/d; p = 0.015) and mean sleeping (active: 1.60 ± 0.20 kcal/min; sham: 1.47 ± 0.17 kcal/min; p = 0.038) EE were significantly increased after active vs. sham CPAP. Findings suggest that CPAP may correct a hypoxia-related adaptive decrease in thermogenesis.

Keywords: Sleep apnoea, Energy expenditure, Obesity, CPAP, Indirect calorimetry

Introduction

The regulation of energy expenditure (EE) in obstructive sleep apnoea (OSA) is complex. Frequent nocturnal arousals, increased respiratory effort, and enhanced sympathetic outflow may increase EE in OSA [1]. However, hypoxemia reduces metabolic rate [2]. Findings on EE in OSA are mixed: some report increases [1,3,4] or no difference [5,6] in sleeping and 24-h EE in patients vs. controls. Few have assessed the effects of continuous positive airway pressure (CPAP) on EE using indirect calorimetry [1,6]. These found that ~2—3 mo of treatment either reduced [1] or had no effect [6,7] on sleeping and resting EE, respectively, vs. base-line. This is the first placebo-controlled crossover study to investigate the effects of CPAP on EE in obese OSA patients using whole-room indirect calorimetry (WRIC).

Methods

Participants were recently diagnosed with OSA but CPAP naïve. Following enrolment, participants began using CPAP at their titrated setting at home. After 2 mo, participants entered the WRIC chamber at ~08:00 for measurements of 24-h EE. WRIC details have been previously described [8]. In the chamber, participants were fed a weight-maintenance diet (30% energy from fat, 55% from carbohydrates, 15% from protein), with energy intake estimated from the Harris—Benedict equation with an activity factor of 1.5 [8]. At 15:15 and 20:15, participants performed 15 min of cycling on a stationary bicycle (65 W, 50 rpm). In-lab sleep was recorded via wrist actigraphy (Actigraph LLC, Pensacola, FL). The first intervention phase was followed by a 1-mo washout (no CPAP). Participants then crossed over into the sham phase, consisting of 2-mo sham treatment and a second 24-h lab visit.

Sham-CPAP devices delivered a sub-therapeutic pressure <1 cm H2O, measured via gauge manometer, despite normal settings [9]. A flow-restricting connector (BiPAP test adaptor 0.25-inch, Respironics, Murrysville, PA) was attached to the machine outlet. Four extra 4-mm holes were drilled into the mask for expelling excess CO2. Noise and settings of sham and active devices were identical.

Procedures were approved by the Institutional Review Board of St. Luke’s-Roosevelt Hospital/Columbia University. All participants provided written informed consent.

Results

Participants were 3 obese males, with mild-to-moderate OSA and daytime sleepiness (Table 1).

Table 1.

Participant characteristics at baseline.

Participant Sex Age (y) BMI (kg/m2) AHI (events/h) CPAP pressure setting (cm H2O) ESS
1 M 51 31.7 12.2 6 9
2 M 46 33.6 26.5 8 12
3 M 55 30.9 26.6 14 9
Mean ± SD 50.7 ± 4.5 32.1 ± 1.4 21.8 ± 8.3 9.3 ± 4.2 10 ± 1.7

Participants were recently diagnosed with obstructive sleep apnoea and had undergone continuous positive airway pressure (CPAP) titration, but had not yet initiated CPAP treatment. Exclusion criteria included apnoea—hypopnoea index >50 events/h, type 2 diabetes, severe hypertension (blood pressure >160/100 mmHg), and any recent near-miss or prior auto accidents. BMI: body mass index; AHI: apnoea—hypopnoea index; ESS: Epworth Sleepiness Scale.

Twenty-four-hour EE was significantly higher during active vs. sham CPAP (Table 2). Mean EE throughout the wake episode was significantly higher in active vs. sham. Mean EE during the sleep episode was significantly higher in active vs. sham. Mean EE during the afternoon, but not evening, exercise session was significantly higher in active vs. sham. Wake episode EE remained significantly higher in active vs. sham when the exercise sessions were removed.

Table 2.

The effects of active and sham CPAP on EE and sleep.

Active CPAP Sham CPAP p-value
EE
Total 24-h EE, kcal/d 2970 ± 254 2705 ± 217 0.015
Mean daily EE, kcal/min 2.06 ± 0.18 1.88 ± 0.15 0.015
Mean wake episode EE, kcal/min 2.32 ± 0.19 2.11 ± 0.16 0.011
Mean wake episode (exercise sessions removed) EE, kcal/min 2.16 ± 0.22 1.96 ± 0.18 0.017
Mean sleep episode EE, kcal/min 1.60 ± 0.20 1.47 ± 0.17 0.038
Mean exercise EE, session 1, kcal/min 6.64 ± 1.29 6.06 ± 1.29 0.02
Mean exercise EE, session 2, kcal/min 7.03 ± 1.42 6.60 ± 1.09 0.151
Sleep
SOL, min 7.33 ± 2.52 10.67 ± 6.66 0.3
TST, min 441.3 ± 10.02 416.67 ± 12.10 0.002
SE, % 92.14 ± 2.48 86.92 ± 2.32 0.004
WASO, min 30.3 ± 11.37 52.0 ± 13.77 0.034

CPAP: continuous positive airway pressure; EE: energy expenditure; Total 24-h EE total 23-h EE extrapolated to 24 h; Mean daily mean value throughout the 23-h recording period; Mean wake episode mean value throughout times spanning the laboratory wake episode from 8:00 to 23:00; Mean sleep episode mean value throughout times spanning the laboratory sleep episode from 23:00 to 07:00. Mean exercise mean value throughout times spanning the exercise session in the afternoon (session 1: 15:15—15:30) and evening (session 2: 20:15—20:30). CPAP: continuous positive airway pressure; SOL: sleep onset latency; TST: total sleep time; SE: sleep efficiency; WASO: wake after sleep onset. p-values are by paired-samples t-tests, with bold indicating statistically significant differences (p < 0.05). Data are expressed as mean ± SD, n = 3.

Total daily prescribed energy intake was 2325 ± 187 kcal.

No difference in sleep latency was observed (Table 2). Significant increases in total sleep time and sleep efficiency were observed in active vs. sham. Wake after sleep onset was significantly lower in active vs. sham.

Discussion

Our finding of a ~9% increase in sleeping EE after active vs. sham CPAP contrasts with the only other study to measure daily EE via WRIC after CPAP, which observed a ~16% decrease in sleeping EE [1]. A sham condition was not used in that study; pre- and post-treatment were compared [1]. Our reported increase in sleeping EE may be related to the adaptive decrease in thermogenesis found in OSA patients [5,10]. Specifically, a negative correlation was reported between time spent in a hypoxic state, indicative of high OSA severity, and daily and sleeping EE [10]. A higher severity of OSA-related hypoxia is also associated with lower than expected daily and sleeping EE [5]. Our results suggest that CPAP may correct this adaptive decrease in thermogenesis.

Although CPAP was applied only during sleep, we observed increased waking EE, which suggests that CPAP may increase activity-induced thermogenesis and exercise thermogenesis. The increase in 24-h EE is not driven solely by increases in exercise EE, since values were still higher during active vs. sham when exercise periods were removed. No imposed standardised exercise regimen was included in the Stenlof et al. study [1], although this is common in WRIC investigations [11]. Furthermore, the diet served while in the chamber by Stenlof et al. was based on a dietary questionnaire reported by participants three days before initial laboratory entry [1]. Diet in our study was calculated based on weight maintenance energy requirements, and balanced for macronutrient content. This is important since OSA severity is associated with increased preference for calorie-rich foods high in fat and carbohydrate [12].

Our small sample size likely contributes to variance in the data, although this may be mitigated by the crossover design. Participant homogeneity may reduce some variability, but may also limit generalisability. This was not a randomised trial: all participants received the active followed by sham phase. Nevertheless, we observed that CPAP increases sleeping and daily EE. Further studies are indicated to replicate findings and assess the impact of CPAP on energy balance.

Acknowledgments

This study was supported by the National Institutes of Health grant T32DK007559, a New York Obesity Research Center Pilot & Feasibility grant (DK26687), and was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1 TR000040, formerly the National Center for Research Resources, Grant Number UL1 RR024156. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Footnotes

Conflict of interest

None of the authors have any conflict of interest related to this manuscript.

Author contributions

AS and M-PS-O designed the study; AS, TF, RR, and M-PS-O performed experiments; AS, TF, RR, and M-PS-O analysed data and interpreted results; AS and M-PS-O drafted the manuscript; AS, TF, RR, and M-PS-O edited and revised manuscript; AS, TF, RR, and M-PS-O approved final version of manuscript

Contributor Information

Ari Shechter, New York Obesity Research Center, Department of Medicine, Columbia University, New York, NY, United States.

Tiffany Pham, Institute of Human Nutrition, Columbia University, New York, NY, United States.

Russell Rising, New York Obesity Research Center, Department of Medicine, Columbia University, New York, NY, United States.

References

  • 1.Stenlof K, Grunstein R, Hedner J, Sjostrom L. Energy expenditure in obstructive sleep apnea: effects of treatment with continuous positive airway pressure. Am J Physiol. 1996;271:E1036–E1043. doi: 10.1152/ajpendo.1996.271.6.E1036. [DOI] [PubMed] [Google Scholar]
  • 2.Gershan WM, Forster HV, Lowry TF, Korducki MJ, Forster AL, Forster MA, et al. Effect of metabolic rate on ventilatory roll-off during hypoxia. J Appl Physiol. 1994;76:2310–2314. doi: 10.1152/jappl.1994.76.6.2310. [DOI] [PubMed] [Google Scholar]
  • 3.Lin CC, Chang KC, Lee KS. Effects of treatment by laser-assisted uvuloplasty on sleep energy expenditure in obstructive sleep apnea patients. Metabolism. 2002;51:622–627. doi: 10.1053/meta.2002.31969. [DOI] [PubMed] [Google Scholar]
  • 4.Ucok K, Aycicek A, Sezer M, Fidan F, Akgun L, Akkaya M, et al. Resting metabolic rate and anthropometric measurements in male sleep apnea patients. Intern Med. 2011;50:833–838. doi: 10.2169/internalmedicine.50.4779. [DOI] [PubMed] [Google Scholar]
  • 5.Hins J, Series F, Almeras N, Tremblay A. Relationship between severity of nocturnal desaturation and adaptive thermogenesis: preliminary data of apneic patients tested in a whole-body indirect calorimetry chamber. Int J Obes (Lond) 2006;30:574–577. doi: 10.1038/sj.ijo.0803159. [DOI] [PubMed] [Google Scholar]
  • 6.Ryan CF, Love LL, Buckley PA. Energy expenditure in obstructive sleep apnea. Sleep. 1995;18:180–187. doi: 10.1093/sleep/18.3.180. [DOI] [PubMed] [Google Scholar]
  • 7.Smurra M, Philip P, Taillard J, Guilleminault C, Bioulac B, Gin H. CPAP treatment does not affect glucose-insulin metabolism in sleep apneic patients. Sleep Med. 2001;2:207–213. doi: 10.1016/s1389-9457(00)00079-4. [DOI] [PubMed] [Google Scholar]
  • 8.Shechter A, Rising R, Albu JB, St-Onge MP. Experimental sleep curtailment causes wake-dependent increases in 24-h energy expenditure as measured by whole-room indirect calorimetry. Am J Clin Nutr. 2013;98:1433–1439. doi: 10.3945/ajcn.113.069427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Marshall NS, Neill AM, Campbell AJ, Sheppard DS. Randomised controlled crossover trial of humidified continuous positive airway pressure in mild obstructive sleep apnoea. Thorax. 2005;60:427–432. doi: 10.1136/thx.2004.032078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Major GC, Series F, Tremblay A. Does the energy expenditure status in obstructive sleep apnea favour a positive energy balance? Clin Invest Med. 2007;30:E262–E268. doi: 10.25011/cim.v30i6.2955. [DOI] [PubMed] [Google Scholar]
  • 11.Grunwald GK, Melanson EL, Forster JE, Seagle HM, Sharp TA, Hill JO. Comparison of methods for achieving 24-hour energy balance in a whole-room indirect calorimeter. Obes Res. 2003;11:752–759. doi: 10.1038/oby.2003.105. [DOI] [PubMed] [Google Scholar]
  • 12.Beebe DW, Miller N, Kirk S, Daniels SR, Amin R. The association between obstructive sleep apnea and dietary choices among obese individuals during middle to late childhood. Sleep Med. 2011;12:797–799. doi: 10.1016/j.sleep.2010.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES